120 results in Exploration of Digestive Diseases
Most Cited
Sort by :
- Latest
- Most Viewed
- Most Downloaded
- Most Cited
Open Access
Review
The central role of mitochondrial metabolism in hepatic steatosis
Sanda Win ... Filbert Win Min Aung
Published: February 29, 2024 Explor Dig Dis. 2024;3:42–68
This article belongs to the special issue Mitochondria and Lipid Signalling in Liver Diseases
Open Access
Review
Mitochondrial ROS, a trigger for mitochondrial dysfunction and inflammasome activation and a therapeutic target in liver diseases
Hala Saeed Jaara, Sandra Torres
Published: December 10, 2024 Explor Dig Dis. 2024;3:474–503
This article belongs to the special issue Mitochondria and Lipid Signalling in Liver Diseases
Open Access
Editorial
Extra-hepatic cancers in metabolic fatty liver syndromes
Amedeo Lonardo
Published: February 24, 2023 Explor Dig Dis. 2023;2:11–17
Open Access
Review
Impact of mitochondrial lipid alterations on liver disease mechanisms and progression
Laura Fàbrega ... Carmen Garcia-Ruiz
Published: September 10, 2024 Explor Dig Dis. 2024;3:382–413
This article belongs to the special issue Mitochondria and Lipid Signalling in Liver Diseases
Open Access
Review
Extracellular vesicles in metabolic dysfunction associated fatty liver disease: mechanisms, diagnostic and therapeutic implications
Zongmei Wu ... Han Moshage
Published: July 13, 2022 Explor Dig Dis. 2022;1:4–20
Open Access
Review
Helicobacter pylori and gastric cancer: a critical approach to who really needs eradication
Elias Kouroumalis ... Argyro Voumvouraki
Published: April 16, 2024 Explor Dig Dis. 2024;3:107–142
This article belongs to the special issue Helicobacter Pylori and Infection: Genomics, Diagnosis, Pathogenesis, Antibiotic Resistance, Microbiota, Cancer, Prevention and Therapeutics
Open Access
Review
The multiple mechanisms and modes of cell death after acetaminophen overdose
Hartmut Jaeschke, Anup Ramachandran
Published: April 07, 2025 Explor Dig Dis. 2025;4:100569
Open Access
Review
Drug-induced cholestasis: causative agents and challenges in diagnosis and management
Jose M. Pinazo-Bandera ... Miren García-Cortés
Published: September 18, 2023 Explor Dig Dis. 2023;2:202–222
This article belongs to the special issue CHOLESTASIS
Open Access
Review
Helicobacter pylori infection and metabolic syndrome
Natalia V. Baryshnikova ... Alexander N. Suvorov
Published: September 10, 2024 Explor Dig Dis. 2024;3:414–427
This article belongs to the special issue Helicobacter Pylori and Infection: Genomics, Diagnosis, Pathogenesis, Antibiotic Resistance, Microbiota, Cancer, Prevention and Therapeutics
Open Access
Review
Zebrafish as a model for drug induced liver injury: state of the art and beyond
Gulcin Cakan-Akdogan ... Ozlen Konu
Published: April 26, 2023 Explor Dig Dis. 2023;2:44–55
This article belongs to the special issue Drug-induced Liver Injury: From Bench to Clinical Application
Open Access
Review
Deciphering the liver enigma: distinguishing drug-induced liver injury and metabolic dysfunction-associated steatotic liver disease—a comprehensive narrative review
Miren García-Cortés ... Alberto García-García
Published: December 27, 2023 Explor Dig Dis 2023;2:318–336
This article belongs to the special issue Drug-induced Liver Injury: From Bench to Clinical Application
Open Access
Perspective
The intermicrovillar adhesion complex in gut barrier function and inflammation
Bernadette Mödl ... Robert Eferl
Published: October 11, 2022 Explor Dig Dis. 2022;1:72–79
Open Access
Review
Role of cholesterol homeostasis in MASH-driven hepatocellular carcinoma: not just a neutral fat
Vicent Ribas
Published: June 14, 2024 Explor Dig Dis. 2024;3:203–225
This article belongs to the special issue Mitochondria and Lipid Signalling in Liver Diseases
Open Access
Review
Metabolic dysfunction-associated steatotic liver disease (MASLD): emerging insights into gut microbiota interactions and therapeutic perspectives
Wenchu Qian ... Haifang Li
Published: June 30, 2025 Explor Dig Dis. 2025;4:100579
This article belongs to the special issue The Role of Gut Microbiota in the Pathogenesis and Management of Metabolic-Associated Steatotic Liver Disease (MASLD)
Open Access
Review
Bile as a liquid biopsy matrix: potential applications and limitations
Maria Arechederra ... Carmen Berasain
Published: February 04, 2024 Explor Dig Dis. 2024;3:5–21
Open Access
Review
MASLD vs. MAFLD. A narrative review
Amedeo Lonardo ... Mohammed Eslam
Published: August 14, 2025 Explor Dig Dis. 2025;4:100586
Open Access
Review
Alcohol-related liver disease: also a question of what you drink?
Finn Jung ... Ina Bergheim
Published: June 30, 2023 Explor Dig Dis. 2023;2:118–132
Open Access
Review
Ultra-processed food consumption and the risk of non-alcoholic fatty liver disease—What are the proposed mechanisms?
Franziska A. Hägele ... Anja Bosy-Westphal
Published: August 24, 2023 Explor Dig Dis. 2023;2:133–148
Open Access
Review
Principles of risk stratification in nonalcoholic fatty liver disease. A narrative review emphasizing non-invasive strategies
Amedeo Lonardo
Published: August 30, 2023 Explor Dig Dis. 2023;2:188–201
This article belongs to the special issue Advances in Hepato-gastroenterology: Diagnosis, Prognostication, and Disease Stratification
Open Access
Review
Etiopathogenesis and pathophysiology of cholestasis
Maitane Asensio ... Jose J. G. Marin
Published: October 31, 2022 Explor Dig Dis. 2022;1:97–117
This article belongs to the special issue CHOLESTASIS
PreviousJournal Information